148 results on '"Fecal Microbiota Transplantation"'
Search Results
2. Lactococcus lactis HkyuLL 10 suppresses colorectal tumourigenesis and restores gut microbiota through its generated alpha-mannosidase.
3. Protective function of sclerosing cholangitis on IBD.
4. Revisiting the donor screening protocol of faecal microbiota transplantation (FMT): a systematic review.
5. Mixed-donor faecal microbiota transplantation was associated with increased butyrate-producing bacteria for obesity.
6. Smart capsules for sensing and sampling the gut: status, challenges and prospects.
7. The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease.
8. Changes in signalling from faecal neuroactive metabolites following dietary modulation of IBS pain.
9. Poking at probiotic mechanisms and microbial implications in cancer prevention and treatment.
10. Microbiome is the key to preventing anastomotic leak in colorectal surgery.
11. Gut microbiota influence anastomotic healing in colorectal cancer surgery through modulation of mucosal proinflammatory cytokines.
12. Akkermansia muciniphila counteracts the deleterious effects of dietary emulsifiers on microbiota and host metabolism.
13. Gnotobiotic mice housing conditions critically influence the phenotype associated with transfer of faecal microbiota in a context of obesity.
14. Longitudinal transkingdom gut microbial approach towards decompensation in outpatients with cirrhosis.
15. Human gut microbiota after bariatric surgery alters intestinal morphology and glucose absorption in mice independently of obesity.
16. Obesity promotes a leaky gut, inflammation and pre-diabetes by lowering gut microbiota that metabolise ethanolamine.
17. Key metabolomic alterations are associated with ulcerative colitis disease state and activity: a validation analysis.
18. Microbial determinants of effective donors in faecal microbiota transplantation for UC.
19. Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial.
20. Modulation of gut microbiota impacts diet-induced and druginduced alopecia in mice.
21. Puerarin alleviates atherosclerosis via the inhibition of Prevotella copri and its trimethylamine production.
22. What defines a healthy gut microbiome?
23. SARS-CoV-2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or diabetes: long-term results of the COVIDPAN study.
24. Gnotobiotic mice housing conditions makes the difference in the context of obesity!
25. Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial.
26. Evaluating microbial determinants of donor efficacy to translate faecal microbiota transplantation from research to clinical practice.
27. Novel scheme for non-invasive gut bioinformation acquisition with a magnetically controlled sampling capsule endoscope.
28. Gut microbiota changes are detected in asymptomatic very young children with SARSCoV-2 infection.
29. Rapid gut dysbiosis induced by stroke exacerbates brain infarction in turn.
30. Niche-specific functional heterogeneity of intestinal resident macrophages.
31. Western-type diet influences mortality from necrotising pancreatitis and demonstrates a central role for butyrate.
32. Location-specific cell identity rather than exposure to GI microbiota defines many innate immune signalling cascades in the gut epithelium.
33. Mixed-donor faecal microbiota transplantation was associated with increased butyrate-producing bacteria for obesity.
34. Rapid resolution of COVID-19 after faecal microbiota transplantation.
35. Mitochondrial impairment drives intestinal stem cell transition into dysfunctional Paneth cells predicting Crohn's disease recurrence.
36. Mitochondrial dysfunction during loss of prohibitin 1 triggers Paneth cell defects and ileitis.
37. The role of gut microbiota in cancer treatment: friend or foe?
38. Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic.
39. microRNA overexpression in slow transit constipation leads to reduced NaV1.5 current and altered smooth muscle contractility.
40. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.
41. Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice.
42. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time.
43. Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn's disease.
44. Scientific frontiers in faecal microbiota transplantation: joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE).
45. Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer.
46. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice.
47. Fifty-point IBS-SSS responders but persistence of moderate severity IBS in over 40% of those on diet.
48. Association between duodenal bile salts and gastric emptying in patients with functional dyspepsia.
49. Human defensin 5-based compounds: a new approach to fight obesity?
50. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.